Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool beats massage for Post-Workout neck pain?

NCT ID NCT07609498

Symptom relief Sponsor: Green International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two methods to reduce delayed onset muscle soreness (DOMS) in the neck and upper back: instrument-assisted soft tissue mobilization (IASTM) and myofascial release. Fifty-eight adults aged 30–40 with DOMS received one of the treatments. The IASTM group showed greater improvements in pain, disability, and range of motion compared to myofascial release.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Instrument assisted soft tissue mobilization (IASTM) and myofascial release
What this could lead to
If IASTM proves consistently better, it could become a go-to technique for quickly easing muscle soreness after exercise.
What could go wrong
This is a small, single-center study with only 58 participants. Results may not apply to everyone, and the long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

58 people

The number who actually took part.

Started

Apr 2026

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 40 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants aged between 30 and 40 years. * Individuals presenting with delayed onset muscle soreness (DOMS) in the cervicothoracic region. * Willingness to participate in either the IASTM or myofascial release intervention protocols. * Ability to understand and sign the informed consent form. Exclusion Criteria: * History of recent cervical or thoracic spine surgery, fractures, or severe trauma in the region. * Presence of open wounds, active skin infections, or severe dermatological conditions in the cervicothoracic area where interventions will be applied. * Diagnosed neurological deficits, cervical radiculopathy, or myelopathy. * Known contraindications to soft tissue mobilization or manual therapy (e.g., severe osteoporosis, bleeding disorders, or anticoagulant use). * Current use of muscle relaxants, heavy analgesics, or NSAIDs that could mask DOMS symptoms during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Delayed onset muscle soreness (DOMS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Myalgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Delayed onset muscle soreness (DOMS) Muscle soreness Myalgia

Contacts and locations

Locations

  • Green International University

    Lahore, Sheikhupura, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.